XML 67 R54.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-based compensation expense - Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2023
Sep. 30, 2023
Shares    
Beginning balance (in shares) 2,119,000  
Forfeited (in shares) (85,000)  
Exercised (in shares) (58,000)  
Ending balance (in shares) 1,976,000 2,119,000
Number of options, Nonvested at December 31, 2022 (in shares) 19,000  
Number of options, Exercisable (in shares) 1,958,000  
Weighted average exercise price per share    
Beginning balance (in usd per share) $ 24.18  
Forfeited (in usd per share) 34.45  
Exercised (in dollars per share) 16.42  
Ending balance (in usd per share) 23.97 $ 24.18
Weighted average exercise price per share, Nonvested at December 31, 2022 (in dollars per share) 77.89  
Vested and exercisable (in usd per share) $ 23.46  
Weighted average remaining contractual term (years)    
Outstanding 1 year 10 months 9 days 5 years 3 months
Weighted average remaining contractual term (years), Nonvested at December 31, 2022 5 years 5 months 23 days  
Weighted average remaining contractual term (years), Exercisable 1 year 9 months 25 days  
Aggregate Intrinsic Value    
Aggregate intrinsic value, outstanding beginning balance $ 6,715  
Exercised 483  
Aggregate intrinsic value, nonvested 5  
Aggregate intrinsic value, Vested and exercisable 29,946  
Aggregate intrinsic value, outstanding ending balance $ 29,951 $ 6,715
Performance Stock Options    
Shares    
Beginning balance (in shares) 289,000  
Forfeited (in shares) (12,000)  
Ending balance (in shares) 277,000 289,000
Number of options, Nonvested at December 31, 2022 (in shares) 30,000 30,000
Number of options, Exercisable (in shares) 247,000 259,000
Weighted average exercise price per share    
Beginning balance (in usd per share) $ 60.82  
Forfeited (in usd per share) 67.85  
Ending balance (in usd per share) 60.53 $ 60.82
Weighted average exercise price per share, Nonvested at December 31, 2022 (in dollars per share) 31.29 31.29
Vested and exercisable (in usd per share) $ 64.07 $ 64.24
Weighted average remaining contractual term (years)    
Outstanding 7 years 1 month 17 days 7 years 4 months 13 days
Weighted average remaining contractual term (years), Nonvested at December 31, 2022 8 years 3 months 25 days 8 years 6 months 25 days
Weighted average remaining contractual term (years), Exercisable 6 years 11 months 26 days 7 years 2 months 23 days
Aggregate Intrinsic Value    
Aggregate intrinsic value, outstanding beginning balance $ 0  
Aggregate intrinsic value, nonvested   $ 0
Aggregate intrinsic value, Vested and exercisable 251 0
Aggregate intrinsic value, Nonvested at December 31, 2022 167  
Aggregate intrinsic value, outstanding ending balance $ 418 $ 0